CA9 and breast neoplasm: Lock et al. have reported CSC depletion due to CAIX inhibition in orthotopic breast tumor models, but also a lack of CSC expansion in vitro when coupled with CAIX inhibition, indicating that immune-unrelated mechanisms are at play as well [20].